'''25N-NBOMe''' ('''2C-N-NBOMe''', '''NBOMe-2C-N''') is a derivative of the [[phenethylamine]] derived hallucinogen [[2C-N]]. It is believed to act in a similar manner to related compounds such as [[25I-NBOMe]] and [[25C-NBOMe]], which are potent [[agonist]]s at the [[5HT2A receptor|5HT<sub>2A</sub>]] [[Receptor (biochemistry)|receptor]].<ref>{{Cite doi|10.1021/cn400216u}}</ref><ref>[http://bitnest.ca/external.php?id=%2518%253A3%25172%251BE%2524K%255BG%2521%2524%257D%2504%2504V Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.]</ref> The pharmacological properties of 25N-NBOMe have not been described in the literature, but only in anecdotal reports.<ref>{{cite web|title=The Big & Dandy 25N-NBOMe Thread|url=http://www.bluelight.org/vb/threads/539694-The-Big-amp-Dandy-25N-NBOMe-Thread}}</ref> 25N-NBOMe has been sold as a street drug and has only been described in the literature in terms of identification by forensic analysis.<ref>{{cite journal|last=Casale|first=John F.|coauthors=Hays, Patrick A.|title=Characterization of Eleven 2,5-Dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) Derivatives and Differentiation from their 3- and 4-Methoxybenzyl Analogues - Part I|journal=Microgram Journal|year=2012|volume=9|issue=2|pages=84–109|url=http://www.justice.gov/dea/pr/microgram-journals/2012/mj9_84-109.pdf|accessdate=14 January 2014}}</ref>
'''25N-NBOMe''' ('''2C-N-NBOMe''', '''NBOMe-2C-N''') is a derivative of the [[phenethylamine]] derived hallucinogen [[2C-N]]. It is believed to act in a similar manner to related compounds such as [[25I-NBOMe]] and [[25C-NBOMe]], which are potent [[agonist]]s at the [[5HT2A receptor|5HT<sub>2A</sub>]] [[Receptor (biochemistry)|receptor]].<ref>{{Cite doi|10.1021/cn400216u}}</ref><ref>[http://bitnest.ca/external.php?id=%2518%253A3%25172%251BE%2524K%255BG%2521%2524%257D%2504%2504V Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.]</ref> The pharmacological properties of 25N-NBOMe have not been described in the literature, but only in anecdotal reports.<ref>{{cite web|title=The Big & Dandy 25N-NBOMe Thread|url=http://www.bluelight.org/vb/threads/539694-The-Big-amp-Dandy-25N-NBOMe-Thread}}</ref> 25N-NBOMe has been sold as a street drug and has only been described in the literature in terms of identification by forensic analysis.<ref>{{cite journal|last=Casale|first=John F.|author2=Hays, Patrick A.|title=Characterization of Eleven 2,5-Dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) Derivatives and Differentiation from their 3- and 4-Methoxybenzyl Analogues - Part I|journal=Microgram Journal|year=2012|volume=9|issue=2|pages=84–109|url=http://www.justice.gov/dea/pr/microgram-journals/2012/mj9_84-109.pdf|accessdate=14 January 2014}}</ref>
25N-NBOMe (2C-N-NBOMe, NBOMe-2C-N) is a derivative of the phenethylamine derived hallucinogen 2C-N. It is believed to act in a similar manner to related compounds such as 25I-NBOMe and 25C-NBOMe, which are potent agonists at the 5HT2Areceptor.[1][2] The pharmacological properties of 25N-NBOMe have not been described in the literature, but only in anecdotal reports.[3] 25N-NBOMe has been sold as a street drug and has only been described in the literature in terms of identification by forensic analysis.[4]
^Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1021/cn400216u, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1021/cn400216u instead.
